Monitoring the prevalence of diabetes and the quality of care using electronic health data

Size: px
Start display at page:

Download "Monitoring the prevalence of diabetes and the quality of care using electronic health data"

Transcription

1 Monitoring the prevalence of diabetes and the quality of care using electronic health data Roberto Gnavi 1 Roberta Picariello 1, Graziella Bruno 2, Carlo Giorda 3, Giuseppe Costa 1,4 1 Epidemiology Unit ASL TO3, Piedmont Region; 2 Department of Internal Medicine, University of Torino; 3 Metabolism and Diabetes Unit, ASL TO5, Piedmont Region; 1,4 Department of Public Health, University of Torino, Italy EUROEPI 2010, Florence, 8 th November 2010

2 Background Worldwide prevalence of diabetes is estimated to be 2.8%, but in more developed societies has reached about 6% The number of people with diabetes is increasing: in the next 20 years the number of persons with diabetes will more than double (an epidemic) Mortality is up to three times greater than that of non-diabetic people To increase the survival of diabetic patients, changes in lifestyle, appropriate drug treatment, regular glycaemic control, and the continuous surveillance of health status are necessary Surveillance systems monitoring the occurrence of the disease over geographical areas and time and the quality of care received by persons with diabetes are needed to allow timely identification of critical cal points and rational planning of interventions

3 Objectives To report a selection of results from a population-based surveillance program, implemented in the city of Turin (900,000 inhabitants) Italy, based on administrative databases and aimed to monitor the occurrence of diabetes and the quality of care

4 Population with diabetes: data sources Exemption from payment: exemption from payment of drugs and laboratory tests because of a diagnosis of DM Regional Drug Prescriptions Database: All residents who had at least two prescriptions of antidiabetic drugs (ATC A10A and A10B) in 2003 Hospital Discharge Database: All residents discharged with a primary or secondary diagnosis of diabetes (ICD9 CM 250) from 1995 to 2002

5 Distribution of persons with diabetes by source of ascertainment 31 st July 2003 Exemption from payment for drugs Hospital discharges ( ) n = Drug Prescriptions Turin Population Register (at least two prescriptions in to 2003) include people alive and resident on 31 st July 2003 to determine individual educational level

6 Prevalence of diabetes in residents of Turin; 2003 Three sources Adjusted for undercount (capture recapture) n % n % difference (%) Gender Donne , ,66 78,6 Uomini , ,90 82,2 Age < , ,40 77, , ,60 81,5 > , ,31 83,4 ALL , ,77 80,4

7 Prevalence of diabetes by educational level in residents > 20 ys. old; Turin 2003 Men Women Prevalence (%) PRR* Prevalence (%) PRR* (95% CI) (95% C I) (95% C I) (95% C I) Educational level High ( ) ( ) Medium ( ) ( ) ( ) ( ) Low ( ) ( ) ( ) ( ) * Adjusted for age Nutr Metab Cardiovasc Dis 2008; 18:

8 To monitor the quality of the process of care of diabetes Regional Register Diabetes residents in (14%) (14%) Hospital discharges residents in Turin with diabetes (3%) Torino Population Register Drug Prescriptions to include people alive on 31st July 2003 to determine individual educational level to determine census tract median income 1 year Regional data base of ambulatory and outpatient care Drug prescriptions Hospital discharges therapy (insulin, oral drugs, diet only) circulatory disease

9 Laboratory test and outpatient consultations in persons with diabetes in Turin Test 1 year % 2 year % Glycosylated Hb Cholesterol Microalbuminuria Eye examination ECG Diabetologist GCI * * Guidelines Composite Indicator A1C + two among eye examination / cholesterol / microalbumiuria

10 Laboratory test and outpatient consultations in persons with diabetes in Turin Gender Eye A1C Cholesterol M.albuminuria Diabetologist examination ECG GCI PR PR PR PR PR PR PR women men 1,01 0,99 1,04 1,01 1,05 1,08 1,02 Age ,99 1,11 0,98 1,08 0,96 1,48 1, ,08 1,21 1,05 1,15 0,98 1,81 1, ,11 1,28 0,95 1,17 0,91 1,94 1,04 >=75 0,96 1,01 0,56 0,97 0,55 1,55 0,62 Educational level high medium 1,05 1,04 1,02 1,08 1,11 1,16 1,05 low 1,04 1,00 0,98 1,11 1,08 1,18 1,00 Treatment diet only oral drugs 1,74 1,35 1,97 1,83 1,84 1,36 1,98 insulin 1,84 1,35 2,18 1,98 2,11 1,42 2,21 Diabetes Care 2009;32:

11 Adherence to guidelines in persons with diabetes in Turin by health district of residence; Prevalence Ratios Prevalence Ratio

12 To monitor the outcomes of care of diabetes Regional Register Diabetes (14%) (14%) ,036 residents Hospital discharges residents with diabetes (1 st january 2002) (3%) Torino Population Register Drug Prescriptions to include people alive on 31st July 2003 to determine individual educational level to determine census tract median income 4 years f.u. MORTALITY All causes Chd Stroke Cancer AMPUTATIONS INCIDENCE Ami Stroke

13 Outcomes: Standard. Mortality/Incidence Ratio (ref. without diabetes) Men Women n SMR/SIR n SMR/SIR Mortality All Circulatory diseases CHD Cerebrovascular disease Cancer Incidence Ami Stroke Amputations

14 Outcomes: mortality/incidence by educational level in diabetic and non diabetic men Diabetics Non diabetics Educational level Medium Elementary Medium Elementary HR HR p for trend HR HR p for trend Mortality All <0.001 Circulatory diseases <0.001 Incidence AMI <0.001 stroke <0.001 Amputations

15 Outcomes: mortality/incidence by educational level in diabetic and non diabetic women Diabetics Non diabetics Educational level Medium Elementary Medium Elementary HR HR p for trend HR HR p for trend Mortality All <.0001 Circulatory diseases <.0001 Incidence AMI stroke <.0001 Amputations

16 Conclusions It is possible, with administrative data, to identify large cohorts of persons with known diabetes, to calculate the prevalence of the disease, and to monitor prospectively, at population level, several indicators that are used internationally to asses the quality of care This allows, in a simple way and at very low cost, to monitor the epidemiology of diabetes and to identify some strengths and weakness of the care system

17 Thank you for your attention

DETERMINANTS OF QUALITY IN DIABETES CARE PROCESS: THE POPULATION BASED TORINO STUDY

DETERMINANTS OF QUALITY IN DIABETES CARE PROCESS: THE POPULATION BASED TORINO STUDY Diabetes Care Publish Ahead of Print, published online August 12, 2009 DETERMINANTS OF QUALITY IN DIABETES CARE PROCESS: THE POPULATION BASED TORINO STUDY Roberto Gnavi MD 1, Roberta Picariello BSc 1,

More information

... Methods. Roberto Gnavi 1, Alessandro Migliardi 1, Moreno Demaria 2, Alessio Petrelli 1, Adele Caprioglio 1, Giuseppe Costa 1,3.

... Methods. Roberto Gnavi 1, Alessandro Migliardi 1, Moreno Demaria 2, Alessio Petrelli 1, Adele Caprioglio 1, Giuseppe Costa 1,3. European Journal of Public Health, Vol. 17, No. 5, 492 496 ß The Author 2007. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved. doi:10.1093/eurpub/ckm005

More information

Declaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations.

Declaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations. Declaration of Conflict of Interest No potential conflict of interest to disclose with regard to the topics of this presentations. Clinical implications of smoking relapse after acute ischemic stroke Furio

More information

... Introduction. Chiara Seghieri 1, Laura Policardo 2, Paolo Francesconi 2, Giuseppe Seghieri 2,3

... Introduction. Chiara Seghieri 1, Laura Policardo 2, Paolo Francesconi 2, Giuseppe Seghieri 2,3 Guideline composite indicator 219 2012. Available at: http://www.euro.centre.org/data/ltc_final.pdf (20 November 2013, date last accessed). 26 Freysson L, Wahrig L. General Governmental Expenditures in

More information

SUPPLEMENTAL MATERIALS

SUPPLEMENTAL MATERIALS SUPPLEMENTAL MATERIALS Table S1: Variables included in the propensity-score matching Table S1.1: Components of the CHA 2DS 2Vasc score Table S2: Crude event rates in the compared AF patient cohorts Table

More information

EuroPrevent 2010 Fatal versus total events in risk assessment models

EuroPrevent 2010 Fatal versus total events in risk assessment models EuroPrevent 2010 Fatal versus total events in risk assessment models Pekka Jousilahti, MD, PhD,Research Professor National Institute for Health and Welfare, Finland Risk assessment models Estimates the

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schnabel RB, Aspelund T, Li G, et al. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010;170(21):1909-1917. eappendix.

More information

Appendix Identification of Study Cohorts

Appendix Identification of Study Cohorts Appendix Identification of Study Cohorts Because the models were run with the 2010 SAS Packs from Centers for Medicare and Medicaid Services (CMS)/Yale, the eligibility criteria described in "2010 Measures

More information

PATTERN OF DIABETES THERAPEUTIC PRESCRIPTION IN RURAL AND URBAN AREAS IN QUEBEC

PATTERN OF DIABETES THERAPEUTIC PRESCRIPTION IN RURAL AND URBAN AREAS IN QUEBEC PATTERN OF DIABETES THERAPEUTIC PRESCRIPTION IN RURAL AND URBAN AREAS IN QUEBEC COMPARAISON DES PROFILS THÉRAPEUTIQUES CHEZ LES PATIENTS DIABÉTIQUES ENTRE RÉGIONS RURALES ET URBAINES AU QUÉBEC Research

More information

The Diabetes Epidemic in Korea

The Diabetes Epidemic in Korea Review Article Endocrinol Metab 2016;31:349-33 http://dx.doi.org/.3803/enm.2016.31.3.349 pissn 2093-96X eissn 2093-978 The Diabetes Epidemic in Korea Junghyun Noh Department of Internal Medicine, Inje

More information

TAHFA-South Texas HFMA Fall Symposium. Tuesday, October 17, from 10:45 AM 11:35 AM.

TAHFA-South Texas HFMA Fall Symposium. Tuesday, October 17, from 10:45 AM 11:35 AM. 1 TAHFA-South Texas HFMA Fall Symposium Tuesday, October 17, from 10:45 AM 11:35 AM. Dr. Anil T. Mangla, MS., PhD., MPH., FRSPH Director of Public Health and Associate Professor of Biomedical Science 2

More information

CLINICAL PROCESS IMPROVEMENT INITIATIVE (CPII) EFFICIENCY REPORT EXPLANATION January 4, 2016

CLINICAL PROCESS IMPROVEMENT INITIATIVE (CPII) EFFICIENCY REPORT EXPLANATION January 4, 2016 CLINICAL PROCESS IMPROVEMENT INITIATIVE (CPII) EFFICIENCY REPORT EXPLANATION January 4, 2016 WHAT IS AN EPISODE OF CARE? An episode of care is a grouping of a patient s health care claims for a unique

More information

Diabetes in Manitoba 1989 to 2006 R E P O R T O F D I A B E T E S S U R V E I L L A N C E

Diabetes in Manitoba 1989 to 2006 R E P O R T O F D I A B E T E S S U R V E I L L A N C E Diabetes in Manitoba 1989 to 2006 R E P O R T O F D I A B E T E S S U R V E I L L A N C E May 2009 Key Results Diabetes Prevalence Manitoba has experienced a considerable growth in the number of people

More information

Diabetes in Manitoba: Trends among Adults

Diabetes in Manitoba: Trends among Adults Diabetes Among Adults in Manitoba (1989-2013) Diabetes in Manitoba: Trends among Adults 1989-2013 1989-2013 Epidemiology & Surveillance Active Living, Population and Public Health Branch Manitoba Health,

More information

A competing risk model to estimate the hospitalisation story of a cohort of diabetic patients. The additive regression model.

A competing risk model to estimate the hospitalisation story of a cohort of diabetic patients. The additive regression model. A competing risk model to estimate the hospitalisation story of a cohort of diabetic patients. The additive regression model. PHD Thesis Project Rosalba Rosato Dept.of Statistics, University of Florence,

More information

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Randi Selmer Senior Researcher Norwegian Institute of Public Health Norway

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Randi Selmer Senior Researcher Norwegian Institute of Public Health Norway PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (see an example) and are provided with free text boxes to

More information

AHA Clinical Science Special Report: November 10, 2015

AHA Clinical Science Special Report: November 10, 2015 www.canheart.ca High-density lipoprotein cholesterol and cause-specific mortality: A population-based study of more than 630,000 individuals without prior cardiovascular conditions Dennis T. Ko, MD, MSc;

More information

Seniors Health in York Region

Seniors Health in York Region Seniors Health in York Region Seniors in York Region are generally healthy York Region is set to experience tremendous growth in its seniors population. A Profile of Baby Boomers and Seniors in York Region,

More information

Characteristics of Philadelphia Census Tracts with High Prostate Cancer Risk

Characteristics of Philadelphia Census Tracts with High Prostate Cancer Risk Characteristics of Philadelphia Census Tracts with High Prostate Cancer Risk Charnita Zeigler-Johnson, PhD, MPH Thomas Jefferson University Philadelphia, PA Using Cancer Registry Data in Disparities Research

More information

Cardiovascular. Mathew Mercuri PhD(C), Sonia S Anand MD PhD FRCP(C)

Cardiovascular. Mathew Mercuri PhD(C), Sonia S Anand MD PhD FRCP(C) Cardiovascular Disease IN THE MÉTIS NATION OF ONTARIO Clinical Significance report March 2012 Mathew Mercuri PhD(C), Sonia S Anand MD PhD FRCP(C) Abstract Cardiovascular disease (CVD) is the leading cause

More information

Zhao Y Y et al. Ann Intern Med 2012;156:

Zhao Y Y et al. Ann Intern Med 2012;156: Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled

More information

A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia

A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia Jari Tiihonen, Jari Haukka, Mark Taylor, Peter M. Haddad, Maxine X. Patel, Pasi Korhonen The American

More information

Preventive Cardiology Scientific evidence

Preventive Cardiology Scientific evidence Preventive Cardiology Scientific evidence Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College London Primary prevention

More information

Translating Health Services Research in Sickle Cell Disease to Policy

Translating Health Services Research in Sickle Cell Disease to Policy Translating Health Services Research in Sickle Cell Disease to Policy Jean L. Raphael, MD, MPH Associate Professor of Pediatrics Baylor College of Medicine Director, Center for Child Health Policy and

More information

Patterns and Cost of Health Care Transitions to Adult Care among Youth with Chronic Conditions in Ontario: A Population Based Cohort Study

Patterns and Cost of Health Care Transitions to Adult Care among Youth with Chronic Conditions in Ontario: A Population Based Cohort Study Patterns and Cost of Health Care Transitions to Adult Care among Youth with Chronic Conditions in Ontario: A Population Based Cohort Study Eyal Cohen, MD, MSc; Sima Gandhi, MSc; Charlotte Moore, MD; Alene

More information

Overview FLORIDA CANCER DATA SYSTEM

Overview FLORIDA CANCER DATA SYSTEM Florida Cancer Data System 1 Florida Cancer Data System 2 FCDS is the legislatively mandated, population-based central cancer registry for the state of Florida. Data in the FCDS are collected from patient

More information

Data Fusion: Integrating patientreported survey data and EHR data for health outcomes research

Data Fusion: Integrating patientreported survey data and EHR data for health outcomes research Data Fusion: Integrating patientreported survey data and EHR data for health outcomes research Lulu K. Lee, PhD Director, Health Outcomes Research Our Development Journey Research Goals Data Sources and

More information

Epidemiologic Measure of Association

Epidemiologic Measure of Association Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2

More information

A nationwide population-based study. Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD

A nationwide population-based study. Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD The Association of Clinical Symptomatic Hypoglycemia with Cardiovascular Events and Total Death in Type 2 Diabetes Mellitus A nationwide population-based study Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD Taipei

More information

Cancer and pharmacoepidemiology in Finland. Information sources and research possibilities

Cancer and pharmacoepidemiology in Finland. Information sources and research possibilities Cancer and pharmacoepidemiology in Finland Information sources and research possibilities What I will talk about Register-based data sources available in Finland Register linkage method Available background

More information

Incorporating External Data into Existing Longitudinal Studies

Incorporating External Data into Existing Longitudinal Studies Incorporating External Data into Existing Longitudinal Studies Public Workshop: Addressing Inadequate Information on Important Health Factors in Pharmacoepidemiology Studies Relying on Healthcare Databases

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix Increased Risk of Atrial Fibrillation and Thromboembolism in Patients with Severe Psoriasis: a Nationwide Population-based Study Tae-Min Rhee, MD 1, Ji Hyun Lee, MD 2, Eue-Keun Choi,

More information

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries. Dr. Christian Finley MD MPH FRCSC McMaster University

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries. Dr. Christian Finley MD MPH FRCSC McMaster University The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University Disclosures I have no conflict of interest disclosures

More information

The prevalence of type 2 diabetes mellitus is increasing CMAJ OPEN. Research

The prevalence of type 2 diabetes mellitus is increasing CMAJ OPEN. Research Hospital admission rates and emergency department use in relation to glycated hemoglobin in people with diabetes mellitus: a linkage study using electronic medical record and administrative data in Ontario

More information

Epidemiology of Asthma. In Wayne County, Michigan

Epidemiology of Asthma. In Wayne County, Michigan Epidemiology of Asthma In Wayne County, Michigan Elizabeth Wasilevich, MPH Asthma Epidemiologist Bureau of Epidemiology Michigan Department of Community Health 517.335.8164 Publication Date: August 2005

More information

Diabetes: Facts and Numbers, 2014

Diabetes: Facts and Numbers, 2014 Diabetes: Facts and Numbers, 2014 Epidemiology of Diabetes Diabetes Control and Treatment Geographical Regions and Diabetes Diabetes Costs Epidemiology of Diabetes Prevalence of Diabetes Prevalence of

More information

Mariza Vono Tancredi. Eliseu Alves Waldman

Mariza Vono Tancredi. Eliseu Alves Waldman Mariza Vono Tancredi Eliseu Alves Waldman RATIONALE The clinical and laboratorial data from a population at a STD/AIDS Referral and Training Center (CRT) in Sao Paulo, Brazil, with 7,853 HIV infected individuals

More information

The TNT Trial Is It Time to Shift Our Goals in Clinical

The TNT Trial Is It Time to Shift Our Goals in Clinical The TNT Trial Is It Time to Shift Our Goals in Clinical Angioplasty Summit Luncheon Symposium Korea Assoc Prof David Colquhoun 29 April 2005 University of Queensland, Wesley Hospital, Brisbane, Australia

More information

SHORT COMMUNICATION. G. Joshy & P. Dunn & M. Fisher & R. Lawrenson

SHORT COMMUNICATION. G. Joshy & P. Dunn & M. Fisher & R. Lawrenson Diabetologia (2009) 52:1474 1478 DOI 10.1007/s00125-009-1380-1 SHORT COMMUNICATION Ethnic differences in the natural progression of nephropathy among diabetes patients in New Zealand: hospital admission

More information

Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study

Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study Thein et al. BMC Cancer (2018) 18:694 https://doi.org/10.1186/s12885-018-4620-2 RESEARCH ARTICLE Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study

More information

Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato Urso, Niek Klazinga, Roberto Ferrari, Nikolaos Maniadakis and Luigi Tavazzi.

Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato Urso, Niek Klazinga, Roberto Ferrari, Nikolaos Maniadakis and Luigi Tavazzi. Appropriateness of prescriptions of recommended treatments in OECD health systems: findings based on the Long-Term Registry of the ESC on Heart Failure Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato

More information

Diabete: terapia nei pazienti a rischio cardiovascolare

Diabete: terapia nei pazienti a rischio cardiovascolare Diabete: terapia nei pazienti a rischio cardiovascolare Giorgio Sesti Università Magna Graecia di Catanzaro Cardiovascular mortality in relation to diabetes mellitus and a prior MI: A Danish Population

More information

PHARMO Database Network

PHARMO Database Network Pros & cons in Oncology studies PHARMO Myrthe Database van Herk-Sukel, Network PhD 1 Disclosure Myrthe van Herk-Sukel is an employee of the PHARMO Institute for Drug Outcomes Research. This independent

More information

Study period Total sample size (% women) 899 (37.7%) Warfarin Aspirin

Study period Total sample size (% women) 899 (37.7%) Warfarin Aspirin Table S2 Sex- specific differences in oral anticoagulant prescription for stroke prevention in AF Total sample size (% women) Anticoagulant(s) studied Gage (2000) 1 Missouri, USA Discharged during 597

More information

6/5/2015. Coccidioidomycosis: An Underreported Cause of Death Arizona, Capture-Recapture

6/5/2015. Coccidioidomycosis: An Underreported Cause of Death Arizona, Capture-Recapture No. Cases per 100,000 Population No. s per 1,000,000 Population 6/5/2015 : An Underreported Cause of Arizona, 2008 2013 Jefferson Jones, MD MPH Arizona Department of Health Services Incidence Rate and

More information

AperTO - Archivio Istituzionale Open Access dell'università di Torino

AperTO - Archivio Istituzionale Open Access dell'università di Torino AperTO - Archivio Istituzionale Open Access dell'università di Torino Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in

More information

Diabetes and the Heart

Diabetes and the Heart Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with

More information

New York State Department of Health Center for Environmental Health

New York State Department of Health Center for Environmental Health New York State Department of Health Center for Environmental Health March 2002 Evaluation of Asthma and Other Respiratory Hospital Admissions among Residents of ZIP Codes 14043 and 14227, Cheektowaga,

More information

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart. Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not

More information

Comparisons of epidemiological data on diabetic and. Incidence and Risk Factors for Stroke in Type 2 Diabetic Patients The DAI Study

Comparisons of epidemiological data on diabetic and. Incidence and Risk Factors for Stroke in Type 2 Diabetic Patients The DAI Study Incidence and Risk Factors for Stroke in Type 2 Diabetic Patients The DAI Study Carlo Bruno Giorda, MD; Angelo Avogaro, MD; Marina Maggini, PhD; Flavia Lombardo, PhD; Edoardo Mannucci, MD; Salvatore Turco,

More information

The impact of diabetes on prescription drug costs: the population-based Turin study

The impact of diabetes on prescription drug costs: the population-based Turin study Diabetologia (2008) 51:795 801 DOI 10.1007/s00125-008-0957-4 ARTICLE The impact of diabetes on prescription drug costs: the population-based Turin study G. Bruno & L. Karaghiosoff & F. Merletti & G. Costa

More information

CURRENT STRATEGIES TO OPTIMALLY TREAT PATIENTS WITH DIABETES AND CVD

CURRENT STRATEGIES TO OPTIMALLY TREAT PATIENTS WITH DIABETES AND CVD Associazione Chaira Medica This event is compliant with the Eucomed Code of Ethical Business Practice (www.ethicalmedtech.eu) 5 th Post-graduate Updating Course CURRENT STRATEGIES TO OPTIMALLY TREAT PATIENTS

More information

Clin Microbiol Infect Feb;21(2):e11-3. doi: /j.cmi Epub 2014 Oct 29.

Clin Microbiol Infect Feb;21(2):e11-3. doi: /j.cmi Epub 2014 Oct 29. This Accepted Author Manuscript (AAM) is copyrighted and published by Elsevier. It is posted here by agreement between Elsevier and the University of Turin. Changes resulting from the publishing process

More information

Supplement materials:

Supplement materials: Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction

More information

Cost-of-illness analysis in the EGB database

Cost-of-illness analysis in the EGB database -of-illness analysis in the EGB database FRESHER WP5 V4.1-06.09.17 CORTAREDONA Sébastien (sebastien.cortaredona@inserm.fr) VENTELOU Bruno (bruno.ventelou@inserm.fr) Changelog: We added a new table Table

More information

EPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS KDIGO. Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas

EPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS KDIGO. Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas EPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas Disclosure of Interests AstraZeneca (scientific advisory board) Bayer

More information

Epidemiology of Asthma. In the Western Michigan Counties of. Kent, Montcalm, Muskegon, Newaygo, and Ottawa

Epidemiology of Asthma. In the Western Michigan Counties of. Kent, Montcalm, Muskegon, Newaygo, and Ottawa Epidemiology of Asthma In the Western Michigan Counties of Kent, Montcalm, Muskegon, Newaygo, and Ottawa Elizabeth Wasilevich, MPH Asthma Epidemiologist Bureau of Epidemiology Michigan Department of Community

More information

Practical Case Studies in Hypertension Management. Series editor Giuliano Tocci Rome, Italy

Practical Case Studies in Hypertension Management. Series editor Giuliano Tocci Rome, Italy Practical Case Studies in Hypertension Management Series editor Giuliano Tocci Rome, Italy The aim of the book series Practical Case Studies in Hypertension Management is to provide physicians who treat

More information

Methodological Framework and Tools for Cross-National comparisons of Drug Utilization Data

Methodological Framework and Tools for Cross-National comparisons of Drug Utilization Data Methodological Framework and Tools for Cross-National comparisons of Drug Utilization Data Vander Stichele RH, MD, PhD Heymans Institute of Pharmacology, Ghent University, Belgium Summer School EACPT August

More information

Variations in Procedure Use

Variations in Procedure Use Variations in Procedure Use in California Laurence Baker Stanford University with funding from the California HealthCare Foundation Study Goal Identify variations in key procedures across geographic g

More information

Hypoglycemia and Quality Measurement

Hypoglycemia and Quality Measurement Hypoglycemia and Quality Measurement Sam Stolpe Senior Director The Triple Aim Affordable Care Better Care Healthy People/ Communities 1 Comprehensive Overview of CMS Quality Programs Hospital Quality

More information

CARDIOVASCULAR DISEASE

CARDIOVASCULAR DISEASE CARDIOVASCULAR DISEASE IN THE MÉTIS NATION OF ONTARIO LAY REPORT MARCH 2012 Prepared by: Clare L. Atzema, MD MSc Moira Kapral, MD MSc Julie Klein-Geltink, MHSc Eriola Asllani, MSc CARDIOVASCULAR DISEASE

More information

Research: Health Economics Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis

Research: Health Economics Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis Research: Health Economics Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis DOI: 10.1111/dme.12858 L. C. Rosella 1,2,3, M. Lebenbaum 2, T. Fitzpatrick 2, D. O Reilly

More information

Treatment disparities for patients diagnosed with metastatic bladder cancer in California

Treatment disparities for patients diagnosed with metastatic bladder cancer in California Treatment disparities for patients diagnosed with metastatic bladder cancer in California Rosemary D. Cress, Dr. PH, Amy Klapheke, MPH Public Health Institute Cancer Registry of Greater California Introduction

More information

Measuring health care inequalities using the Census- DAD data linkage

Measuring health care inequalities using the Census- DAD data linkage Measuring health care inequalities using the Census- DAD data linkage Erin Pichora, Program Lead Canadian Population Health Initiative Canadian Institute for Health Information November 14, 2017 Epichora@cihi.ca

More information

Coronary Heart Disease in Women Go Red for Women

Coronary Heart Disease in Women Go Red for Women Coronary Heart Disease in Women Go Red for Women Dr Fiona Stewart Green Lane Cardiovascular Service and National Women s Health Auckland City Hospital Auckland Heart Group Women are Different from Men

More information

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:

More information

The University of Mississippi School of Pharmacy

The University of Mississippi School of Pharmacy LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke «L Europe de la santé au service des patients» 13-14 October 2008 - Institut Pasteur Paris Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke Simona Giampaoli National Centre of

More information

Deprivation and Health. A report by the National Public Health Service for Wales

Deprivation and Health. A report by the National Public Health Service for Wales Deprivation and Health A report by the National Public Health Service for Wales Copyright 24 National Public Health Service for Wales All rights reserved. Any unauthorised copying without prior permission

More information

9 Diabetes care. Back to contents

9 Diabetes care. Back to contents Back to contents Diabetes is a major risk factor for the development of peripheral vascular disease and 349/628 (55.6%) of the patients in this study had diabetes. Hospital inpatients with diabetes are

More information

GSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source

GSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Diabetes Education Columbus Community Hospital Stacy Biesel RN, CDE

Diabetes Education Columbus Community Hospital Stacy Biesel RN, CDE Diabetes Education Columbus Community Hospital Stacy Biesel RN, CDE Stacy Biesel, RN CDE Registered Nurse Certified Diabetes Educator Locations: Columbus Community Hospital Prairie Ridge Health Clinic

More information

Data Sources, Methods and Limitations

Data Sources, Methods and Limitations Data Sources, Methods and Limitations The main data sources, methods and limitations of the data used in this report are described below: Local Surveys Rapid Risk Factor Surveillance System Survey The

More information

Cardiovascular Disease in Tennessee. Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health

Cardiovascular Disease in Tennessee. Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health Cardiovascular Disease in Tennessee Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health Practical Strategies in Medication Adherence for Cardiac and Stroke

More information

Resistant hypertension (RH), that is, blood pressure (BP)

Resistant hypertension (RH), that is, blood pressure (BP) Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus Francesca Viazzi, MD; Pamela Piscitelli, MD; Antonio Ceriello, MD; Paola Fioretto, MD; Carlo Giorda,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Dharmarajan K, Wang Y, Lin Z, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. doi:10.1001/jama.2017.8444 etable

More information

Race Original cohort Clean cohort HR 95%CI P HR 95%CI P. <8.5 White Black

Race Original cohort Clean cohort HR 95%CI P HR 95%CI P. <8.5 White Black Appendix Table 1: Hazard Ratios of the association between CSCs and all-cause mortality from original cohort and the clean cohort excluding CHD/strokes. CSC categories Race Original cohort Clean cohort

More information

Incidence of diabetes among postmenopausal breast cancer survivors

Incidence of diabetes among postmenopausal breast cancer survivors Diabetologia (2013) 56:476 483 DOI 10.1007/s00125-012-2793-9 ARTICLE Incidence of diabetes among postmenopausal breast cancer survivors L. L. Lipscombe & W. W. Chan & L. Yun & P. C. Austin & G. M. Anderson

More information

Peer Educator Networks for Diabetes and chronic NCD in Cambodia. MoPoTsyo Patient Information Centre

Peer Educator Networks for Diabetes and chronic NCD in Cambodia. MoPoTsyo Patient Information Centre Peer Educator Networks for Diabetes and chronic NCD in Cambodia MoPoTsyo Patient Information Centre www.mopotsyo.org Chronic Non Communicable Diseases % of Overweight in Cambodians rising Mortality from

More information

2/10/2016. Perspectives on the 2013 ACC/AHA Cholesterol Guidelines. Disclosures. ATP-III Update 2004

2/10/2016. Perspectives on the 2013 ACC/AHA Cholesterol Guidelines. Disclosures. ATP-III Update 2004 Perspectives on the 2013 ACC/AHA Cholesterol Guidelines Donald M. Lloyd-Jones, MD ScM Senior Associate Dean Chair and Professor of Preventive Medicine Northwestern Feinberg School of Medicine Disclosures

More information

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital 1. Importance of Lowering LDL-Cholesterol in Diabetes Patients & Lipid Guidelines Prevalence of dyslipidemia in Korea Prevalence

More information

Supplementary Information for: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative.

Supplementary Information for: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative. Supplementary Information for: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative. Authors: Pamela Piscitelli 1, Francesca Viazzi 2 ; Paola Fioretto

More information

Estimating RSV Disease Burden in the United States

Estimating RSV Disease Burden in the United States Estimating RSV Disease Burden in the United States Brian Rha, MD, MSPH Medical Epidemiologist, Division of Viral Diseases Centers for Disease Control and Prevention Severe Acute Respiratory Infection Surveillance

More information

Clinical Quality Measures Summary of Upcoming Enhancements

Clinical Quality Measures Summary of Upcoming Enhancements Upcoming coding enhancements will impact the logic behind the clinical quality indicators applicable to your practice specialty. Please refer to this grid for a summary of the coding enhancements and some

More information

ESPEN Congress Florence 2008

ESPEN Congress Florence 2008 ESPEN Congress Florence 2008 Severe obesity - Session organised in conjunction with ASPEN Long term mortality in cohorts of severely obese subjects D. Mirabelli (Italy) Long-term mortality in cohorts of

More information

Status of the CKD and ESRD treatment: Growth, Care, Disparities

Status of the CKD and ESRD treatment: Growth, Care, Disparities Status of the CKD and ESRD treatment: Growth, Care, Disparities United States Renal Data System Coordinating Center An J. Collins, MD FACP Director USRDS Coordinating Center Robert Foley, MB Co-investigator

More information

Finland and Sweden and UK GP-HOSP datasets

Finland and Sweden and UK GP-HOSP datasets Web appendix: Supplementary material Table 1 Specific diagnosis codes used to identify bladder cancer cases in each dataset Finland and Sweden and UK GP-HOSP datasets Netherlands hospital and cancer registry

More information

LATE BREAKING STUDIES IN DM AND CAD. Will this change the guidelines?

LATE BREAKING STUDIES IN DM AND CAD. Will this change the guidelines? LATE BREAKING STUDIES IN DM AND CAD Will this change the guidelines? Objectives 1. Discuss current guidelines for prevention of CHD in diabetes. 2. Discuss the FDA Guidance for Industry regarding evaluating

More information

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012 Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? Easy 89 yo Non-ambulatory Multiple failed interventions Forefoot and heel gangrene Andres Schanzer, MD

More information

Chapter 1: CKD in the General Population

Chapter 1: CKD in the General Population Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table

More information

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Prepared for: American Hospital Association April 4, 2019 Berna Demiralp,

More information

Applications of Pharmacoepidemiology in General Practice 2012 Joint Conference of Drug Safety Research Centres 21 November 2012, Hong Kong

Applications of Pharmacoepidemiology in General Practice 2012 Joint Conference of Drug Safety Research Centres 21 November 2012, Hong Kong Applications of Pharmacoepidemiology in General Practice 2012 Joint Conference of Drug Safety Research Centres 21 November 2012, Hong Kong Martin CS Wong MD, MPH JC School of Public Health and Primary

More information

Project Cohort EXPOSED GROUP

Project Cohort EXPOSED GROUP Project Cohort Study Design Matched cohort study EXPOSED GROUP Index Event / Inclusion Criteria FOR EXPOSED GROUP Index Event: First eligible prescription for a study medication (S_fin, S_dut). Note: the

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL efigures efigure: Standardised differences between TNF-α inhibitor users and non-users before and after matching on fixed factors and propensity scores. etables etable 1: All diagnoses

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Developmental Perspectives on Health Disparities from Conception Through Adulthood Risk Factors for Heart Disease Philip Greenland, MD Harry W. Dingman Professor Chair, Department of Preventive Medicine

More information

Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health

Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Robert Clarke Clinical Trial Service Unit University of Oxford 28 th May

More information

Survey Scottish Diabetes. Survey Monitoring Group

Survey Scottish Diabetes. Survey Monitoring Group Scottish Diabetes Survey 2009 Scottish Diabetes Survey Monitoring Group 2 Foreword The Scottish Diabetes Survey is now in its ninth year. This 2009 Survey, as with previous versions, continues to demonstrate

More information